Skip to main content
European Commission logo
italiano italiano
CORDIS - Risultati della ricerca dell’UE
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary

COVID-19 pandemic: An innovative, safe and effective bio-decontamination technology for non-toxic removal of biological agents, including coronavirus

Descrizione del progetto

Un innovativo prodotto di decontaminazione contro la Covid-19

La maggior parte degli agenti decontaminanti contro gli agenti patogeni, quali la Covid-19 o il virus dell’influenza, sono basati su sostanze chimiche non utilizzabili in modo frequente sulla pelle in quanto possibile causa di complicazioni per la salute. Il progetto ABwipe, finanziato dall’UE, sta sviluppando un prodotto unico che sfrutta il meccanismo di legame dei patogeni. Basato su una matrice di cellulosa, il prodotto contiene leganti carboidrati-proteine con una forte affinità per agenti pandemici quali influenza e coronavirus. Oltre alla sua capacità disinfettante, che ha il potenziale per impedire la diffusione dell’infezione, il materiale sviluppato da ABwipe può essere utilizzato anche in medicina legale e diagnostica per l’identificazione dei patogeni.

Obiettivo

Infectious diseases, such as COVID-19, plague, Ebola, SARS and flu, caused by biological agents, are among the most serious and least predicted threats facing the global community. As we currently experience with the COVID-19 pandemic, bioagents can cause enormous societal and economic damage. Unlike, in the case of chemical, radiological or nuclear incidents, like e.g. in Chernobyl where people could not do much to stop the spread across Europe, in the case of the COVID-19 outbreak, public has a real power to reduce the impact by social distancing, respiratory etiquette, hand hygiene and decontamination in an attempt to flatten the curve.

Current decontamination solutions are suitable for hard surfaces but based on chemicals that cannot be used repeatedly on skin because they are harmful to humans, lead to health complications (hormonal imbalance, allergic reaction and dryness etc.) and damage the environment. There has been a lack of innovation in human-decontamination technologies over the decades and there is a clear need for technologies that can deliver safe, effective and immediate decontamination of human skin. The technological innovation of ABwipe offers a paradigm shift in decontamination.

ABwipe is a unique product, inspired by nature and exploiting the mechanism of pathogen binding. It is made up of a matrix material (cellulose fibres) with attached carbohydrate-protein binders, carefully selected with strong affinities for biothreat agents, including pandemic agents such as influenza and coronavirus. ABwipe not only decontaminates but also captures and contains biological agents. This is a significant capability that reduces the impact, impedes the spread of the infection and allows forensics and diagnostics to identify harmful agents. It is an effective, safer, better and fit for purpose solution for potentially devastating bioagent threat to the society, saving lives, restoring the health of victims and returning contaminated areas to a safe state

Invito a presentare proposte

H2020-EIC-SMEInst-2018-2020

Vedi altri progetti per questo bando

Bando secondario

H2020-EIC-SMEInst-2018-2020-3

Meccanismo di finanziamento

SME-2 - SME instrument phase 2

Coordinatore

AQUILA BIOSCIENCE LIMITED
Contribution nette de l'UE
€ 1 940 968,75
Indirizzo
BALLINAHALLA
Moycullen Galway
Irlanda

Mostra sulla mappa

PMI

L’organizzazione si è definita una PMI (piccola e media impresa) al momento della firma dell’accordo di sovvenzione.

Regione
Ireland Northern and Western West
Tipo di attività
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Collegamenti
Costo totale
€ 2 772 812,50